Optimized and Scalable LNP Composition for RNA Vaccine Delivery

Optimized and scalable LNP composition for RNA vaccine deliveryПодробнее

CMC Considerations for Developing an Effective mRNA/LNP TherapeuticПодробнее

Proteolipid vesicles: A novel delivery system for safe and effective delivery of nucleic acidsПодробнее

Translating mRNA-Based Medicines from Concept to ClinicПодробнее

Rapid mRNA manufacturing for Vaccine DevelopmentПодробнее

TMS 9/12/21 ''Manufacturing of nucleic acid lipid nanoparticles for vaccine development''Подробнее

A Scalable Solution for Large Scale Manufacturing of Vaccine Adjuvants and Delivery SystemsПодробнее

Ionizable Lipids to Optimize RNA-LNP DeliveryПодробнее

Developing Scalable RNA-LNP Drug Products for Clinical ReadinessПодробнее

Ionizable lipids to optimize RNA-LNP delivery - CytivaПодробнее

eTheRNA’s mRNA Lipid Nanoparticles LNP Technology Developed for its Cancer Immunotherapy ProgramsПодробнее

Session 1: Translation of RNA Nanomedicines from Design to Clinical - Dr. Heinrich HaasПодробнее

GenVoy-ILM™ T Cell Kit for mRNA Promotional VideoПодробнее

Manufacturing Lipid NanoparticlesПодробнее

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell TherapyПодробнее

Novel Ionizable Lipid Library for Enabling Non-Viral Delivery – Dr. Lloyd JeffsПодробнее

Accelerate development by outsourcing MRNA–LNP formulations to a CDMOПодробнее

Scalable Manufacturing and Nanovesicle Delivery of CRISPR Cas9 Ribonucleoproteins Using a cGMP...Подробнее